Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Dec. 18, 2019

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Dec. 18, 2019

FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326

Dec. 17, 2019

Aurinia reports data from pivotal study of voclosporin in lupus nephritis

Dec. 5, 2019

New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals

Dec. 4, 2019

AstraZeneca identifies new TRPC3 and TRPC6 antagonists

Nov. 28, 2019

Peroxiredoxin-1 as a novel therapeutic target in LPS-induced AKI

Nov. 28, 2019

Muscarinic acetylcholine M3 receptor positive allosteric modulators patented by Nippon Shinyaku

Nov. 27, 2019

Phase III ADVOCATE trial of avacopan in ANCA vasculitis meets primary endpoints

Nov. 26, 2019

CLCA1-TMEM16A-chloride current pathway mediates renal injury in aging and diabetes

Nov. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...